What should I know first?

Catatonia is a pattern of changes in movement, speech and behavior, not simply a severe form of schizophrenia. Someone may become unusually still and difficult to engage, remain in a posture or repeat movements or words. Others become intensely restless or alternate between reduced and excessive activity.

A person who cannot respond may still be aware of what is happening around them. Catatonia can occur with several psychiatric or medical conditions. This article is a syndrome overview: it does not combine all associated, medical and substance-related diagnoses into one supposedly identical disorder.

Signs and Symptoms

Signs can include markedly reduced movement, little or no speech, prolonged postures, repetitive actions or copying another person’s words or movements. Some people resist movement or appear unable to begin an action. Others show agitation that is not easily explained by their surroundings.

These findings are assessed as a pattern, not diagnosed from one unusual gesture. Eating, drinking and communication may become difficult. Severe immobility can lead to medical complications, while fever, rigidity, unstable vital signs or rapid deterioration are warning signs of a potentially life-threatening presentation.

How Is It Diagnosed?

Clinicians observe the pattern, examine the person and obtain a history of changes from their usual functioning. A structured assessment can help document signs and response to treatment. Investigation seeks both causes and complications; the examination may guide blood tests, brain imaging or seizure testing.

A monitored lorazepam challenge can sometimes support the assessment, but response is not a stand-alone proof and lack of response does not exclude catatonia. This is not a test to attempt at home. DSM and ICD organize associated mental, substance-related and medical presentations differently, so the cause and classification should be stated rather than left implicit.

How Common Is It?

Catatonia is probably underrecognized, and frequency depends strongly on where and how it is assessed. The Royal College of Psychiatrists describes it in roughly one in ten psychiatric inpatients, which is not a general-population prevalence estimate. Rates in medical wards, specialist services and developmental populations cannot be assumed to be the same.

Quiet, withdrawn presentations can be overlooked if staff expect only dramatic immobility. Awareness of the syndrome is important because recognition can change treatment, but a population statistic cannot determine whether an individual’s symptoms are catatonia.

What Causes It?

Catatonia may accompany depression, bipolar disorder, schizophrenia and other conditions. It can also occur with neurological illness, infection, metabolic problems, medication effects or substance withdrawal. Finding a familiar psychiatric diagnosis should not stop a medical assessment. Autistic people can develop catatonia, but longstanding communication or movement differences are not themselves evidence of it: a meaningful change from baseline is especially important.

The precise reason it develops in one person remains uncertain. Treatment therefore needs to address the syndrome and investigate its underlying context, rather than assume one universal cause.

What Do We Know About the Brain?

Research examines how brain systems coordinate movement, emotional responses and voluntary action. Several possible processes may lead to a similar outward pattern, which is one reason catatonia can accompany different illnesses. Current knowledge does not provide a single diagnostic scan or laboratory test.

A response to treatment may be clinically informative without proving one simple explanation of brain function. Describing these limits helps avoid the mistaken idea that reduced movement always reflects either deliberate behavior or one particular psychiatric disease.

Conditions With Similar Symptoms

Delirium, seizures without obvious convulsions, neurological movement disorders and severe medication reactions can resemble parts of catatonia. These conditions may also coexist, so the task is not always to choose only one label. Neuroleptic malignant syndrome, a serious reaction associated with certain medicines, is an important urgent differential when fever and rigidity occur.

Depression-related slowing, longstanding autistic traits and ordinary unwillingness to speak are not automatically catatonia. A careful physical and neurological assessment is essential, particularly when someone deteriorates rapidly or cannot provide a clear history.

Other Conditions That Can Occur Together

The associated illness and the complications of reduced movement may both need active care. Dehydration, malnutrition, pressure injuries, infection and blood clots are among the concerns in a person who is immobile or unable to eat and drink adequately. These are preventable or treatable medical problems, not merely secondary inconveniences.

Anxiety or fear may be intense even when the person appears unresponsive. Supporters can help by describing baseline functioning and recent changes. The treatment team should also attend to communication needs and the person’s dignity throughout care.

Treatment and Support

Care often requires a setting able to monitor physical health and provide nutrition, fluids and protection from immobility-related complications. Treatment of catatonia and treatment of the underlying condition may need to proceed together. Benzodiazepines and electroconvulsive therapy are central specialist treatments; which is used first depends on urgency, contraindications and the clinical situation.

ECT is performed with anesthesia and medical monitoring, not as a punishment or a behavioral response. Its potential benefits, memory effects and other risks should be discussed through an appropriate consent process. Severe or malignant catatonia requires urgent specialist management rather than routine observation.

In a child or adolescent, a marked loss of usual movement, speech, eating or everyday skills needs urgent specialist assessment. A 2026 pediatric expert consensus recommends early evaluation of psychiatric, developmental and medical causes, with supervised treatment and repeated monitoring. It does not provide a home treatment plan; young people may need hospital-level care.

Can Medication Help?

Lorazepam is commonly used under supervision and can improve movement and responsiveness even though it is usually described as a sedating medicine. Clinicians monitor effects, breathing, sedation and interactions. There is no safe one-size-fits-all home regimen. Abrupt discontinuation after regular treatment can cause problems and may be followed by recurrence, so any reduction needs an agreed plan.

Antipsychotics are not a blanket treatment for catatonia and can worsen some presentations or increase concern about neuroleptic malignant syndrome. If psychosis is also present, the team must weigh treatment choices carefully rather than simply increasing an antipsychotic.

What to Expect Over Time

Many people improve with treatment, sometimes quickly, but speed and completeness of recovery vary with the cause and duration. Persistent symptoms or recurrence require reassessment rather than a conclusion that the person is choosing not to recover. Improvement in movement does not necessarily mean the underlying illness or physical complications have resolved.

Follow-up should address those problems and review medication needs. People may also want help making sense of a frightening episode. A plan for recognizing early changes can be useful, especially if catatonia has occurred before.

Everyday Life and Support

Speak respectfully and explain what you are doing, even when a person cannot answer. Familiar, calm support can reduce fear, and accounts from relatives or caregivers may be valuable with appropriate safeguards. Do not force food, drink or medicine into someone who cannot swallow safely; seek clinical help.

Avoid interpreting immobility or silence as laziness or defiance. After recovery, ask what the person remembers and what support they would prefer in any future episode. New marked reduction in movement or speech, inability to drink, fever or rapidly changing physical status warrants urgent assessment.

History

Karl Kahlbaum described catatonia in the nineteenth century as a pattern that could cross diagnostic boundaries. Later classifications linked it strongly with schizophrenia, and older records may refer to catatonic schizophrenia. That historical association was too narrow. Modern classifications recognize catatonia in mood disorders, other psychiatric conditions and medical or substance-related presentations.

DSM-5 removed the old schizophrenia subtype and made the broader use of catatonia clearer. ICD-11 gives catatonia its own grouping while also distinguishing secondary medical presentations. This change matters clinically: a person who becomes immobile or stops speaking should not automatically be assumed to have schizophrenia.

Current care combines recognition of the syndrome with urgent attention to physical complications and investigation of its cause.

Sources and References

The British Association for Psychopharmacology guideline provides specialist assessment and treatment guidance. Royal College and UCL materials explain the experience for patients and supporters. WHO and the historical APA classification document clarify why catatonia is not confined to schizophrenia. NIMH explains ECT and its risks, while MedlinePlus supports the delirium distinction. This is an educational syndrome overview, not a self-test, medication schedule or claim that one diagnostic code applies to every presentation.

  1. Evidence-based consensus guidelines for the management of catatonia (2023)
  2. Catatonia (2022-04)
  3. Catatonia: information for patients and carers
  4. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024)
  5. Highlights of Changes from DSM-IV-TR to DSM-5 (2013)
  6. Brain Stimulation Therapies
  7. Delirium
  8. Pediatric Catatonia Clinical Pathway: Delphi Consensus Study
  9. NIMH: Understanding psychosis

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top